AiCuris Anti-infective Cures AG today announced that its registrational Phase 3 trial (PRIOH-1, NCT03073967) of

October 16, 2025 No Comments

We are continuing our new series, Media Day, where we spotlight individual medical institutions and infectious

October 16, 2025 No Comments

ViiV Healthcare presented data this week showing that 69% of participants rated CAB injections as

October 15, 2025 No Comments

Panelists discuss how managing pediatric atopic dermatitis (AD) requires prioritizing the symptoms that most disrupt

October 15, 2025 No Comments

Panelists discuss how living with atopic dermatitis (AD) deeply affects children and their families, extending

October 15, 2025 No Comments

A retrospective service-improvement review from a UK hepatology program found that one third of adults

October 15, 2025 No Comments

The trial evaluating dalbavancin for Staphylococcus aureus bloodstream infections used Desirability of Outcome Ranking (DOOR)

October 14, 2025 No Comments

Treatment of hepatitis C virus (HCV) during the early phase (within 24 weeks of infection)

October 14, 2025 No Comments

Antimicrobial stewardship emphasizes the rapid initiation of appropriate therapy, with ceftaroline emerging as an effective

October 14, 2025 No Comments

We are continuing our new series, Media Day, where we spotlight individual medical institutions and infectious

October 13, 2025 No Comments

Schedule an Appointment

Quick Links